Impact of conditioning intensity in T-replete haplo-identical stem cell transplantation for acute leukemia: a report from the acute leukemia working party of the EBMT.
Fiche publication
Date publication
mars 2016
Journal
Journal of hematology & oncology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr RUBIO Marie Thérèse
Tous les auteurs :
Rubio MT, Savani BN, Labopin M, Piemontese S, Polge E, Ciceri F, Bacigalupo A, Arcese W, Koc Y, Beelen D, Gülbas Z, Wu D, Santarone S, Tischer J, Afanasyev B, Schmid C, Giebel S, Mohty M, Nagler A
Lien Pubmed
Résumé
Increasing numbers of patients are receiving haplo-identical stem cell transplantation (haplo-SCT) for treatment of acute leukemia with reduced intensity (RIC) or myeloablative (MAC) conditioning regimens. The impact of conditioning intensity in haplo-SCT is unknown.
Mots clés
Acute Disease, Adult, Antineoplastic Combined Chemotherapy Protocols, therapeutic use, Cyclophosphamide, administration & dosage, Cytarabine, administration & dosage, Disease-Free Survival, Female, Graft vs Host Disease, prevention & control, Hematopoietic Stem Cell Transplantation, methods, Humans, Leukemia, Myeloid, therapy, Male, Melphalan, administration & dosage, Middle Aged, Multivariate Analysis, Mycophenolic Acid, administration & dosage, Neoplasm Recurrence, Local, Precursor Cell Lymphoblastic Leukemia-Lymphoma, therapy, Retrospective Studies, Transplantation Conditioning, methods, Treatment Outcome
Référence
J Hematol Oncol. 2016 Mar 15;9:25